Clinical Trial Update: A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients [Phase 1]

View source ↗

Summary

Phase 1b trial evaluates safety of MB097 in combination with pembrolizumab for melanoma; study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MB097
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Microbiotica Ltd | Conditions: Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING